Poly Medicure Share Price
Small Cap | Pharmaceuticals and health care | NSE: POLYMED | BSE: 531768
₹2,400.00 
69.25 (2.97 %)
Last Updated: 01 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 2,398.85
High (₹) 2,480.00
Low (₹) 2,280.05
Prev. Close (₹) 2,330.75
Volume 11,232
VWAP (₹) 2,320.21
ROCE (%) 23.42
Industry P/E 75.40
TTM P/E 82.47
P/B Ratio 15.89
Market Cap (₹) Cr.24,661.67
Dividend Yield (%)0.13
EPS (₹) 26.90
ROE17.56%
Sales Growth (%) 23.36
Profit Growth (%)44.19
Day Range
2,480.002,480.00
52 Week Range
1,373.003,350.00
Historical Returns
Returns (6M)
31.88 %
Returns (1Y)
57.66 %
Returns (3Y)
171.02 %
Returns (5Y)
729.59 %
Returns (6M)
31.88 %
Returns (1Y)
57.66 %
Returns (3Y)
171.02 %
Returns (5Y)
729.59 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (44.08%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 44.08% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 39.32
MFI 51.48
ATR 128.11
Commodity Channel Index -89.69
ROC125 24.51
ROC21 -10.69
Williams %R -44.68
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2,352.80 | 2,374.85 | 2,400.30 | 2,327.35 | 2,305.30 | 2,279.85 | 2,257.80 |
| Week Ago | 2,492.15 | 2,542.00 | 2,613.95 | 2,420.20 | 2,370.35 | 2,298.40 | 2,248.55 |
| Month Ago | 2,678.29 | 2,746.97 | 2,798.59 | 2,626.67 | 2,557.99 | 2,506.37 | 2,437.69 |
EMA & SMA
2400.00
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
14
5 Day 2351.28
9 Day 2400.42
10 Day 2410.18
12 Day 2424.11
14 Day 2439.63
20 Day 2538.22
26 Day 2535.05
50 Day 2648.45
100 Day 2589.66
200 Day 2241.71
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| LIGHTHOUSE INDIA III EQUITY INVESTORSLIMITED | bulk | Sell | 21 Feb, 2024 | ₹1,550.06 | 12,90,939 | BSE |
| BNP PARIBAS ARBITRAGE | block | Sell | 25 Jan, 2024 | ₹1,450.70 | 1,01,686 | BSE |
| SOCIETE GENERALE | block | Buy | 25 Jan, 2024 | ₹1,450.70 | 1,01,686 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 17 Aug, 2023 | RISHI BAID | Disposal | ₹1,473.925410821643286573146293 | 24,950 | BSE |
| 14 Aug, 2023 | RISHI BAID | Disposal | ₹1,472.696838733075435203094778 | 99,264 | BSE |
| 01 Apr, 2022 | RISHI BAID | Disposal | ₹943.6326666666666666666666667 | 30,000 | BSE |
| 29 Mar, 2022 | RISHI BAID | Disposal | ₹847.6737333333333333333333333 | 60,000 | BSE |
| 28 Mar, 2022 | RISHI BAID | Disposal | ₹846.9419 | 10,000 | BSE |
| 01 Jul, 2021 | VCB TRADING LLP | Disposal | ₹995.00 | 1,00,000 | BSE |
| 11 Mar, 2020 | J.K. SANCHETI OSWAL | Acquisition | ₹289.0088888888888888888888889 | 450 | BSE |
| 11 Mar, 2020 | NIDHI OSWAL DAUGHTER OF CFO | Disposal | ₹309.4333333333333333333333333 | 210 | BSE |
| 11 Mar, 2020 | J.K. SANCHETI OSWAL | Disposal | ₹309.4666666666666666666666667 | 900 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 17 May, 2024 | Rs.3.0000 per share(60%)Final Dividend | 19 Sept, 2024 | 01 Jan, 1970 |
| 09 May, 2023 | Rs.3.0000 per share(60%)Final Dividend | 21 Sept, 2023 | 01 Jan, 1970 |
| 24 May, 2022 | Rs.2.5000 per share(50%)Final Dividend | 16 Sept, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 29 Jan, 2025 | NSE India | Poly Medicure Limited has informed the Exchange about Schedule of meet |
| 29 Jan, 2025 | BSE India | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 03rd February, 2025 at 16:30 P.M. (IST) for discussing the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024. |
| 27 Jan, 2025 | NSE India | POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 03-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
| 27 Jan, 2025 | BSE India | POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve The Company informed the Exchange about the Board Meeting to be held on 03rd February, 2025. |
| 25 Jan, 2025 | NSE India | Poly Medicure Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot |
| 25 Jan, 2025 | BSE India | The Company declared of voting results of postal ballot Pursuant to Regulation 44(3) of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 along with scrutinizers report. |
| 14 Jan, 2025 | NSE India | Poly Medicure Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 14 Jan, 2025 | NSE India | POLY MEDICURE LIMITED has informed the Exchange regarding Joint venture agreements |
| 31 Dec, 2024 | NSE India | POLY MEDICURE LIMITED has informed the Exchange about Closure of Trading Window |
| 31 Dec, 2024 | NSE India | Poly Medicure Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 29 Jan, 2025 | 03 Feb, 2025 |
| Quarterly Results & ESOP | -- | 22 Oct, 2024 | 28 Oct, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 22 Jul, 2024 |
| Others | Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. | 17 Jul, 2024 | 29 Jun, 2024 |
| Audited Results & Final Dividend | -- | 07 May, 2024 | 17 May, 2024 |
| Others | Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). | 05 Mar, 2024 | 08 Mar, 2024 |
| Quarterly Results | -- | 20 Jan, 2024 | 31 Jan, 2024 |
| Quarterly Results | -- | 26 Oct, 2023 | 04 Nov, 2023 |
| Quarterly Results | -- | 27 Jul, 2023 | 07 Aug, 2023 |
| Audited Results & Final Dividend | -- | 04 May, 2023 | 09 May, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Aug, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Poly Medicure
Poly Medicure is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 1307.25 Cr. and Equity Capital is Rs. 47.99 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. Himanshu Baid
NSE Symbol
POLYMED
Poly Medicure Management
| Name | Designation |
|---|---|
| Mr. Devendra Raj Mehta | Chairman |
| Mr. Himanshu Baid | Managing Director |
| Mr. Rishi Baid | Joint Managing Director |
| Mr. Jugal Kishore Baid | Non Executive Director |
| Mrs. Mukulika Baid | Non Executive Director |
| Mr. Alessandro Balboni | Non Executive Director |
| Dr. Shailendra Raj Mehta | Ind. Non-Executive Director |
| Dr. Ambrish Mithal | Ind. Non-Executive Director |
| Dr. Sandeep Bhargava | Ind. Non-Executive Director |
| Mr. Vimal Bhandari | Ind. Non-Executive Director |
| Mr. Amit Khosla | Ind. Non-Executive Director |
| Ms. Sonal Mattoo | Ind. Non-Executive Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Poly Medicur | ₹25,612.61 | ₹2,433.90  ₹2,330.00(4.46%) | ₹1,360.950 - ₹3,350.000 |
| Tarsons Prod | ₹2,259.94 | ₹370.50  ₹373.45(-0.79%) | ₹377.750 - ₹551.750 |
| Boro.Scienti | ₹1,482.71 | ₹164.34 ₹158.22(3.87%) | ₹137.480 - ₹229.800 |
| Vasa Denti | ₹1,217.46 | ₹637.00 ₹659.40(-3.40%) | ₹401.000 - ₹840.000 |
| Prevest Den | ₹695.87 | ₹547.55 ₹567.85(-3.57%) | ₹332.000 - ₹673.000 |
FAQs on Poly Medicure
What is the share price of Poly Medicure?
The share price of Poly Medicure on 01 Feb, 2025 is ₹ 2,400.00.
What is 52W high and 52W low share price of Poly Medicure?
The highest and lowest 52W share prices of Poly Medicure are ₹ 3350.000 and ₹ 1360.950
What is the market cap of Poly Medicure?
The market capitalization of Poly Medicure as of 01 Feb, 2025 is ₹ 24,661.67 Crores
What is the P/E ratio of Poly Medicure?
The current P/E ratio of Poly Medicure as of 01 Feb, 2025 is 75.40
What is the PB ratio of Poly Medicure?
The PB ratio of Poly Medicure as of 01 Feb, 2025 is 15.89
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)